PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-09-15

Date Title Company
15-Sep-2025 HDI Global USA Appoints Himadri Trivedi to Business Transformation Lead Businesswire
15-Sep-2025 Saisei Ventures Appoints James Feliciano as Venture Partner Businesswire
15-Sep-2025 Turn Therapeutics to Host Open Investor Session in Connection with Expected Public Listing on Nasdaq Businesswire
15-Sep-2025 Champions Oncology Reports Record Quarterly Revenue of $14.0 Million ACCESS Newswire
15-Sep-2025 MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet Businesswire
15-Sep-2025 bonyf NV Showcases Innovative Product Portfolio at ExpoPharm 2025 in Düsseldorf bonyf NV
15-Sep-2025 Thermo Fisher Scientific Launches Efficient-Pro Medium (+) Insulin for Enhanced Bioprocessing Performance Businesswire
15-Sep-2025 Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business Businesswire
15-Sep-2025 NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio Businesswire
15-Sep-2025 REDCap Cloud Launches Next-Generation Clinical Trial Data and Analytics Platform to Power AI-Driven Research Businesswire
15-Sep-2025 GLASGOW FIRMS HELP ALZHEIMER RESEARCHERS TAKE A LEAP FORWARD WITH NEW SCANNER TECHNOLOGY Wideblue
15-Sep-2025 Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates Businesswire
15-Sep-2025 BODYWELLE Hosts Event Featuring Commissioner Kristen Rosen Gonzalez on Local Growth Initiatives ACCESS Newswire
15-Sep-2025 Raludotatug Deruxtecan Granted Breakthrough Therapy Designation by U.S. FDA for Patients with CDH6 Expressing Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancers Previously Treated with Bevacizumab Businesswire
15-Sep-2025 CatalYm Announces Leadership Changes to Accelerate Visugromab Late-stage Clinical Development Businesswire
15-Sep-2025 Atom Therapeutics Enrolls First Patient in Multicenter Global Phase 2 Trial of ABP-745 for Acute Gout Flares Businesswire
15-Sep-2025 Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury Tiziana Life Sciences
15-Sep-2025 EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke Novo Nordisk
15-Sep-2025 Frank Montes De Oca and John Wagner Join the Assistance Fund's Board of Directors ACCESS Newswire
15-Sep-2025 PAO Group Inc Announces New CEO James Schramm ACCESS Newswire